Migraine Relief Spray Shows Promising Clinical Results

LA JOLLA, CA – A clinical study of migraine sufferers using a new over-the-counter homeopathic drug administered as a sublingual spray (under the tongue) resulted in approximately 87% of the participants receiving relief in an average of less than 7 minutes. Researchers at Marshall Blum Clinical Specialists conducted the study of the new sublingual spray and noted that there were no reports of adverse side effects.

Commenting on the study, Dr. James F. Balch, co-author of the best selling book “Prescription for Nutritional Healing” stated, “In my opinion this new spray is the most effective over-the-counter migraine pain reliever to enter the market for two reasons. First, the solution relieves the headache by relaxing blood vessel dilation without suppressing the brain receptors’ ability to feel pain, thereby avoiding rebound headaches. And second, by administering the drug under the tongue patients avoid complications in the gastro-intestinal tract, namely bleeding, which can be caused by traditional OTC pain medications. This revolutionary product will change how migraine sufferers manage their pain.”

The spray’s primary active ingredient, the medicinal herb, feverfew, has been used for centuries in the treatment of headaches, fever and general pain. Other studies of feverfew, including those reported in the prestigious medical publications “The Lancet” and “The British Medical Journal” have demonstrated feverfew’s potential for migraine prevention. These studies showed a statistically significant number of patients reported a reduction in the number and/or severity of migraine attacks when using feverfew on a daily basis for prophylaxis (prevention).

In addition, an ongoing doctor test using MigraSpray for prophylaxis is being conducted in New York City at the Centers for Integrative and Complimentary Medicine. Of the patients studied using MigraSpray on a continual daily basis, approximately 90% have had their migraine headache attacks eliminated.

It’s estimated that 32 million Americans, or nearly 12% of the U.S. population suffer from migraine headaches. Women comprise approximately 76% of sufferers and men 24%. An estimated 150 million workdays a year are lost due to headache pain, costing as much as $13 billion annually in lost productivity.

If you are a healthcare practitioner and would like to make MigraSpray available to your patients please call (800) 454-6790 to place your order or if you are a consumer who would like to order MigraSpray click here or call them toll free at (800) FAST-RELIEF(327-8735).